Study Of Sunitinib With Capecitabine In Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced/Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Sunitinib
Sponsor: Pfizer